Literature DB >> 8974069

Elucidating molecular mechanisms of septic cardiomyopathy--the cardiomyocyte model.

K Werdan1, U Müller-Werdan.   

Abstract

In the multiple organ dysfunction syndrome of sepsis and septic shock the heart is one of the organs subject to failure. Many new insights into the mechanisms underlying septic cardiomyopathy were gained in the last years. Experimental work with neonatal and adult cardiomyocytes considerably contributed to this progress, facilitating the documentation of direct attenuation of the contractions of the heart muscle cell by toxins and mediators, as well as investigating the underlying cellular mechanisms. With this respect, contractile-depressant effects have been found in cardiomyocytes for many toxins and sepsis mediators, with endotoxin, Pseudomonas exotoxin A, tumor necrosis factor alpha, interleukin-1 and nitric oxide being the most relevant ones identified. These substances interfere at clinically relevant concentrations with several main inotropic axes, not only with the beta-adrenoceptor/adenylyl cyclase and with the NO-cGMP-system-on which most of the interest is focused at present-but also with the alpha 1-adrenoceptor/phosphoinositide pathway and the Ca2+ homeostasis of the cardiomyocyte, the latter representing the common final inotropic pathway. Not a single cardiodepressant factor, but more likely a total bunch of toxins and mediators with different attack mechanisms seem to contribute to the picture of septic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8974069     DOI: 10.1007/BF00408670

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  61 in total

1.  Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failure.

Authors:  J Wang; G Zhao; W Shen; M Ochoa; D Moore; J W Hubbard; T H Hintze
Journal:  J Cardiovasc Pharmacol       Date:  1993       Impact factor: 3.105

Review 2.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

Review 3.  Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system.

Authors:  F Murad
Journal:  Adv Pharmacol       Date:  1994

4.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

5.  Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor alpha attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations.

Authors:  P Boekstegers; I Kainz; W Giehrl; W Peter; K Werdan
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

6.  TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients.

Authors:  K A Krown; K Yasui; M J Brooker; A E Dubin; C Nguyen; G L Harris; P M McDonough; C C Glembotski; P T Palade; R A Sabbadini
Journal:  FEBS Lett       Date:  1995-11-27       Impact factor: 4.124

7.  Phase I study of recombinant tumor necrosis factor in cancer patients.

Authors:  M Blick; S A Sherwin; M Rosenblum; J Gutterman
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

8.  Arrhythmias and alpha 1-adrenoceptor binding characteristics of the guinea-pig perfused heart during ischaemia and reperfusion.

Authors:  R G Chess-Williams; D J Sheridan; K J Broadley
Journal:  J Mol Cell Cardiol       Date:  1990-05       Impact factor: 5.000

9.  Cellular mechanisms of endotoxin-induced myocardial depression in rabbits.

Authors:  J Hung; W Y Lew
Journal:  Circ Res       Date:  1993-07       Impact factor: 17.367

10.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.

Authors:  C Natanson; P W Eichenholz; R L Danner; P Q Eichacker; W D Hoffman; G C Kuo; S M Banks; T J MacVittie; J E Parrillo
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  6 in total

Review 1.  [Cytokines and heart diseases. Attempt at an update].

Authors:  K Werdan
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications.

Authors:  Karl Werdan; Anja Oelke; Stefan Hettwer; Sebastian Nuding; Sebastian Bubel; Robert Hoke; Martin Russ; Christine Lautenschläger; Ursula Mueller-Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-02-11       Impact factor: 5.460

Review 3.  Heart rate characteristics: physiomarkers for detection of late-onset neonatal sepsis.

Authors:  Karen D Fairchild; T Michael O'Shea
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

Review 4.  Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy.

Authors:  Ion A Hobai; Jessica Edgecomb; Kara LaBarge; Wilson S Colucci
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

Review 5.  Role of cytokines and inflammation in heart function during health and disease.

Authors:  Monika Bartekova; Jana Radosinska; Marek Jelemensky; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

6.  Ventriculoarterial decoupling in human septic shock.

Authors:  Fabio Guarracino; Baldassare Ferro; Andrea Morelli; Pietro Bertini; Rubia Baldassarri; Michael R Pinsky
Journal:  Crit Care       Date:  2014-04-24       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.